Outcomes for Lumbar Decompressions With Use of Liposomal Bupivicaine
Status:
Not yet recruiting
Trial end date:
2022-01-01
Target enrollment:
Participant gender:
Summary
Evaluate the benefit of using liposomal bupivicaine in lumbar laminectomies in terms of
length of stay, IV narcotic use, 30-day narcotic use, visual analog score (VAS) and 30-day
readmissions